08:00 , Feb 10, 2014 |  BioCentury  |  Finance

A Japanese correction

A Japanese correction Japan's biotechs exhibited the high beta typical of the sector last week, falling more than five times as much as the country's broader markets, which themselves have been taking a beating. Nevertheless,...
08:00 , Jan 6, 2014 |  BC Week In Review  |  Financial News

Human Metabolome Technologies completes IPO

Human Metabolome Technologies Inc. (Tokyo:6090), Tsuruoka, Japan   Business: Diagnostic, Supply/Service   Date completed: 12/24/13   Type: IPO   Raised: ¥1.2 billion ($11.4 million)   Shares: 850,000   Price: ¥1,400   Shares after offering: 4.7...
08:00 , Jan 6, 2014 |  BioCentury  |  Finance

2014 Financial Markets Preview: Hoping the pause is brief

Bankers and buysiders are not expecting a repeat performance of biotech's stellar 2013. But the two dozen who spoke with BioCentury say the capital markets are primed to open back up this month, albeit on...
08:00 , Jan 6, 2014 |  BioCentury  |  Finance

4Q Stock Wrap-Up: All's well that ends well

Although two segments lost ground in 4Q13, all of biotech's market cap groups finished 2013 in the black. Large caps valued at more than $5 billion led the way in the fourth quarter, tacking on...
08:00 , Jan 6, 2014 |  BioCentury  |  Finance

Highlights of weekly biotech stock moves

Regulatory milestones ALK-Abello A/S (CSE:ALK-B) added DKK24 to DKK616 on Christmas week after FDA said its Allergenic Products Advisory Committee will meet on Jan. 28 to discuss a BLA for Ragwitek ragweed Allergy Immunotherapy Tablet...
01:06 , Dec 27, 2013 |  BC Extra  |  Financial News

Human Metabolome jumps in Japanese IPO

Human Metabolome Technologies Inc. (Tokyo:6090) jumped Y1,442 (103%) to Y2,842 in its first day of trading on Tuesday on the Tokyo Stock Exchange's Mothers. The metabolomics service company sold shares at Y1,400 for a valuation...
08:00 , Nov 25, 2013 |  BC Week In Review  |  Financial News

Human Metabolome Technologies proposes IPO

Human Metabolome Technologies Inc. , Tsuruoka, Japan   Business: Diagnostic, Supply/Service   Date announced: 11/22/13   Type: IPO   To be raised: TBD   Shares: 850,000   Price: TBD   Underwriters: Ichiyoshi; Kyokuto Securities; Nomura;...
02:28 , Nov 23, 2013 |  BC Extra  |  Financial News

Human Metabolome planning Tokyo IPO

Human Metabolome Technologies Inc. (Tsuruoka, Japan) received approval to list its shares on the Tokyo Stock Exchange's Mothers. The company is planning to sell 850,000 shares in the offering; the shares are slated to start...
07:00 , Jun 27, 2005 |  BC Week In Review  |  Company News

Human Metabolome Technologies Inc., Agilent deal

The companies partnered to develop a product for high throughput mapping of the human metabolome. The deal combines Human Metabolome's biochemical assays for measuring metabolites in cells and organisms with Agilent's capillary electrophoresis and mass...